Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation

Overview of attention for article published in Arthritis Research & Therapy, June 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,910 followers.

Favorable Efficacy of Rituximab in ANCA-associated Vasculitis Patients With Excessive B Cell Differentiation - PubMed https://t.co/la7BrkShoq

18 Jun 2020

Reply Repost Favourite

RT @vasculitides: Favorable Efficacy of Rituximab in ANCA-associated Vasculitis Patients With Excessive B Cell Differentiation - Arthritis…

18 Jun 2020

Reply Repost Favourite

Favorable Efficacy of Rituximab in ANCA-associated Vasculitis Patients With Excessive B Cell Differentiation - Arthritis Res Ther https://t.co/dYNvEizUlU

18 Jun 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.